TransCon CNP, a sustained-release C-Type Natriuretic Peptide prodrug, a potentially safe and efficacious new therapeutic modality for the treatment of comorbidities associated with FGFR3-related skeletal dysplasias
Breinholt, Vibeke Miller, Rasmussen, Caroline E, Mygind, Per Holse, Kjelgaard-Hansen, Mads, Faltinger, Frank, Bernhard, Ana, Zettler, Joachim, Hersel, UlrichLanguage:
english
Journal:
Journal of Pharmacology and Experimental Therapeutics
DOI:
10.1124/jpet.119.258251
Date:
June, 2019
File:
PDF, 1.04 MB
english, 2019